- Home
- MBRX vs LFWD Comparison
MBRX vs LFWD Comparison
Compare MBRX & LFWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- LFWD
- Stock Information
- Founded
- MBRX 2015
- LFWD 2001
- Country
- MBRX United States
- LFWD Israel
- Employees
- MBRX N/A
- LFWD N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- LFWD
- Sector
- MBRX Health Care
- LFWD
- Exchange
- MBRX Nasdaq
- LFWD NYSE
- Market Cap
- MBRX 12.9M
- LFWD 10.5M
- IPO Year
- MBRX 2016
- LFWD 2014
- Fundamental
- Price
- MBRX $0.57
- LFWD $0.78
- Analyst Decision
- MBRX Strong Buy
- LFWD Strong Buy
- Analyst Count
- MBRX 3
- LFWD 3
- Target Price
- MBRX $5.33
- LFWD $9.00
- AVG Volume (30 Days)
- MBRX 9.6M
- LFWD 807.1K
- Earning Date
- MBRX 08-13-2025
- LFWD 08-14-2025
- Dividend Yield
- MBRX N/A
- LFWD N/A
- EPS Growth
- MBRX N/A
- LFWD N/A
- EPS
- MBRX N/A
- LFWD N/A
- Revenue
- MBRX N/A
- LFWD $25,414,000.00
- Revenue This Year
- MBRX N/A
- LFWD $12.04
- Revenue Next Year
- MBRX N/A
- LFWD $40.58
- P/E Ratio
- MBRX N/A
- LFWD N/A
- Revenue Growth
- MBRX N/A
- LFWD 41.92
- 52 Week Low
- MBRX $0.25
- LFWD $0.50
- 52 Week High
- MBRX $3.67
- LFWD $4.77
- Technical
- Relative Strength Index (RSI)
- MBRX 45.87
- LFWD 43.98
- Support Level
- MBRX $0.74
- LFWD $0.70
- Resistance Level
- MBRX $0.96
- LFWD $0.84
- Average True Range (ATR)
- MBRX 0.13
- LFWD 0.07
- MACD
- MBRX 0.02
- LFWD 0.03
- Stochastic Oscillator
- MBRX 25.85
- LFWD 44.88
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About LFWD REWALK ROBOTICS LTD
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.